# COVID19 OutcomeS in Myeloma and the Impact of VaCcines

> **NCT05831787** · — · COMPLETED · sponsor: **ASH Research Collaborative** · enrollment: 201 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Patient Reported Outcomes

## Key facts

- **NCT ID:** NCT05831787
- **Lead sponsor:** ASH Research Collaborative
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-23
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05831787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05831787, "COVID19 OutcomeS in Myeloma and the Impact of VaCcines". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT05831787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*